You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Clozapine combined with different antipsychotic drugs for treatment‐resistant schizophrenia
|
|---|---|
| Published in |
Cochrane database of systematic reviews, March 2017
|
| DOI | 10.1002/14651858.cd006324.pub3 |
| Pubmed ID | |
| Authors |
Sarah Barber, Uwaila Olotu, Martina Corsi, Andrea Cipriani |
X Demographics
The data shown below were collected from the profiles of 54 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 14 | 26% |
| Spain | 5 | 9% |
| United States | 3 | 6% |
| Mexico | 2 | 4% |
| Malaysia | 1 | 2% |
| Ecuador | 1 | 2% |
| Netherlands | 1 | 2% |
| Denmark | 1 | 2% |
| Japan | 1 | 2% |
| Other | 2 | 4% |
| Unknown | 23 | 43% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 34 | 63% |
| Practitioners (doctors, other healthcare professionals) | 12 | 22% |
| Scientists | 7 | 13% |
| Science communicators (journalists, bloggers, editors) | 1 | 2% |
Mendeley readers
The data shown below were compiled from readership statistics for 383 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 1 | <1% |
| Unknown | 382 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 55 | 14% |
| Student > Bachelor | 45 | 12% |
| Researcher | 36 | 9% |
| Student > Ph. D. Student | 27 | 7% |
| Other | 26 | 7% |
| Other | 70 | 18% |
| Unknown | 124 | 32% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 114 | 30% |
| Nursing and Health Professions | 32 | 8% |
| Psychology | 26 | 7% |
| Pharmacology, Toxicology and Pharmaceutical Science | 20 | 5% |
| Neuroscience | 12 | 3% |
| Other | 46 | 12% |
| Unknown | 133 | 35% |
Attention Score in Context
This research output has an Altmetric Attention Score of 32. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 April 2023.
All research outputs
#1,273,481
of 26,017,215 outputs
Outputs from Cochrane database of systematic reviews
#2,649
of 13,168 outputs
Outputs of similar age
#24,827
of 326,781 outputs
Outputs of similar age from Cochrane database of systematic reviews
#72
of 268 outputs
Altmetric has tracked 26,017,215 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,168 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.9. This one has done well, scoring higher than 79% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 326,781 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 268 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 73% of its contemporaries.